Henry Schein

Henry Schein Equity

The The Equity of Henry Schein (HSIC) as of Oct 30, 2026 is 3.25 B USD. In the previous year, The Equity was 3.39 B USD — a change of -4.36% (lower).

Equity

3.25 BUSD

YoY

-4.36%

Last updated:

In 2025, Henry Schein's equity was 3.25 B USD, a -4.36% increase from the 3.39 B USD equity in the previous year.

The Henry Schein Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
2.96 B USD
Jan 1, 2019
3.00 B USD
Jan 1, 2020
3.35 B USD
Jan 1, 2021
3.43 B USD
Jan 1, 2022
3.45 B USD
Jan 1, 2023
3.66 B USD
Jan 1, 2024
3.39 B USD
Jan 1, 2025
3.25 B USD
The Henry Schein Equity history
YEAREquityYoY
3.25 BUSD-4.36%
3.39 BUSD-7.17%
3.66 BUSD+6.07%
3.45 BUSD+0.61%
3.43 BUSD+2.29%
3.35 BUSD+11.68%
3.00 BUSD+1.24%
2.96 BUSD+5.33%
2.81 BUSD+0.66%
2.79 BUSD-3.16%
2.88 BUSD+2.51%
2.81 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Henry Schein Stock analysis

What does Henry Schein do? Henry Schein Inc is a global provider of medical products and services for the healthcare industry based in Melville, New York. It was founded in 1932 by Henry Schein and has a long history of providing high-quality products and services for the healthcare industry. The company specializes in four core areas: medical products, services, medical software, and veterinary products. In the medical products area, Henry Schein distributes a wide range of medical products and equipment, including dental and orthodontic products, surgical instruments and supplies, medical laboratory equipment and supplies, and furnishings for practices. The company strives to offer its customers the best selection of medical products at a competitive price. Henry Schein also offers services aimed at making the work of healthcare providers easier. For example, the company provides services such as practice management software, online pharmacies, insurance, and billing services to optimize the operation of a medical or veterinary practice. Another important area of the company is medical software. Henry Schein offers an extensive range of software solutions for medical and veterinary practices, as well as hospitals and other medical facilities. The software facilitates tasks such as electronic medical records, appointment scheduling, and financial management, enabling practices and hospitals to operate more efficiently. Henry Schein has also specialized in the field of veterinary medicine, offering a wide range of products and services for veterinarians and animal clinics. The company distributes veterinary instruments, laboratory equipment, surgical instruments, and veterinary medications, and also provides services such as practice management software and veterinary billing. The company aims to provide its customers with a comprehensive range of products and services in a variety of areas. Henry Schein has established itself as an industry leader and is valued for its high quality and excellent customer service. Henry Schein is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Henry Schein's Equity

Henry Schein's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Henry Schein's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Henry Schein's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Henry Schein's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Henry Schein’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Henry Schein stock

The Equity of Henry Schein is 3.25 B USD in 2025.

The Equity of Henry Schein changed from 3.39 B USD to 3.25 B USD, representing a -4.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Henry Schein since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Henry Schein historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Henry Schein

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Henry Schein